These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10486844)

  • 21. [Dyskinesia caused by L-DOPA].
    Derkinderen P; Vidailhet M
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S92-101. PubMed ID: 12690668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microelectrode recording-determined subthalamic nucleus length not predictive of stimulation-induced side effects.
    McClelland S; Kim B; Winfield LM; Ford B; Edwards TA; Pullman SL; Yu Q; McKhann GM; Goodman RR
    Neurosurg Focus; 2005 Nov; 19(5):E13. PubMed ID: 16398463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of dyskinetic disorders with tremor by lesioning and DBS of Vim].
    Zhang J; Wang Z; Zhang X
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):792-3. PubMed ID: 11798967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staged lesions through implanted deep brain stimulating electrodes: a new surgical procedure for treating tremor or dyskinesias.
    Raoul S; Faighel M; Rivier I; Vérin M; Lajat Y; Damier P
    Mov Disord; 2003 Aug; 18(8):933-8. PubMed ID: 12889085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of image fusion for target point determination in functional neurosurgery.
    Duffner F; Schiffbauer H; Breit S; Friese S; Freudenstein D
    Acta Neurochir (Wien); 2002 May; 144(5):445-51. PubMed ID: 12111500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Parkinson's disease: deep brain stimulation].
    Krack P
    Rev Neurol (Paris); 2002; 158(122):135-141. PubMed ID: 12690324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease?
    Peppe A; Gasbarra A; Stefani A; Chiavalon C; Pierantozzi M; Fermi E; Stanzione P; Caltagirone C; Mazzone P
    Parkinsonism Relat Disord; 2008 Aug; 14(6):501-4. PubMed ID: 18337153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up.
    Tavella A; Bergamasco B; Bosticco E; Lanotte M; Perozzo P; Rizzone M; Torre E; Lopiano L
    Neurol Sci; 2002 Sep; 23 Suppl 2():S111-2. PubMed ID: 12548368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of severe Parkinson disease with electric stimulation of the subthalamic nuclei].
    Ostergaard K; Sunde NA; Sørensen JC; Dupont E
    Ugeskr Laeger; 2000 Oct; 162(41):5491-6. PubMed ID: 11068525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
    Maurel F; Lilliu H; Le Pen C
    Rev Neurol (Paris); 2001 May; 157(5):507-14. PubMed ID: 11438770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy and distortion of deep brain stimulation electrodes on postoperative MRI and CT.
    Pinsker MO; Herzog J; Falk D; Volkmann J; Deuschl G; Mehdorn M
    Zentralbl Neurochir; 2008 Aug; 69(3):144-7. PubMed ID: 18666049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility.
    Rousseaux M; Krystkowiak P; Kozlowski O; Ozsancak C; Blond S; Destée A
    J Neurol; 2004 Mar; 251(3):327-34. PubMed ID: 15015014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
    Bejjani BP; Arnulf I; Demeret S; Damier P; Bonnet AM; Houeto JL; Agid Y
    Ann Neurol; 2000 May; 47(5):655-8. PubMed ID: 10805339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech.
    Pinto S; Gentil M; Krack P; Sauleau P; Fraix V; Benabid AL; Pollak P
    Mov Disord; 2005 Nov; 20(11):1507-15. PubMed ID: 16037917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease.
    Brodsky MA; Hogarth P; Nutt JG
    Mov Disord; 2006 Sep; 21(9):1487-90. PubMed ID: 16721730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.
    Thobois S; Mertens P; Guenot M; Hermier M; Mollion H; Bouvard M; Chazot G; Broussolle E; Sindou M
    J Neurol; 2002 May; 249(5):529-34. PubMed ID: 12021940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tandospirone citrate, a selective 5-HT1A agonist, alleviates L-DOPA-induced dyskinesia in patients with Parkinson's disease].
    Kannari K; Kurahashi K; Tomiyama M; Maeda T; Arai A; Baba M; Suda T; Matsunaga M
    No To Shinkei; 2002 Feb; 54(2):133-7. PubMed ID: 11889759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor.
    Diamond A; Shahed J; Jankovic J
    J Neurol Sci; 2007 Sep; 260(1-2):199-203. PubMed ID: 17561121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.